Comparison of rubella seroepidemiology in 17 countries: Progress towards international disease control targets

Bulletin of the World Health Organization

Volumn 86, Issue 2, 2008, Pages 118-125

  Nardone, Anthony ^a   Tischer, Annedore ^b   Andrews, Nick ^a   Backhouse, Jo ^c   Theeten, Heidi ^d   Gatcheva, Nina ^e   Zarvou, Marios ^f   Kriz, Bohumir ^g   Pebody, Richard G ^a   Bartha, Kalman ^h   O'Flanagan, Darina ⁱ   Cohen, Dani ^j   Duks, Arnis ^k   Griskevicius, Algirdas ^l   Mossong, Joel ^m   Barbara, Christopher ⁿ   Pistol, Adrianna ^o   Slačiková, Margareta ^p   Prosenc, Katarina ^q   Johansen, Kari ^r   Miller, Elizabeth ^a   more..

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b ROBERT KOCH INSTITUTE   (Germany)

^c NATIONAL CENTRE FOR IMMUNISATION RESEARCH AND SURVEILLANCE   (Australia)

^d UNIVERSITY OF ANTWERP   (Belgium)

^e NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES   (Bulgaria)

^f NICOSIA GENERAL HOSPITAL   (Cyprus)

^g NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^h NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

ⁱ HEALTH PROTECTION SURVEILLANCE CENTRE   (Ireland)

^j TEL AVIV UNIVERSITY   (Israel)

^k Public Health Agency   (Latvia)

^l Lithuanian AIDS Centre   (Lithuania)

^m LABORATOIRE NATIONAL DE SANTÉ   (Luxembourg)

ⁿ ST LUKE S HOSPITAL   (Malta)

^o NATIONAL INSTITUTE OF PUBLIC HEALTH   (Romania)

^p Public Health Authority of the Slovak Republic   (Slovakia)

^q NATIONAL INSTITUTE OF PUBLIC HEALTH   (Slovenia)

^r SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ASSAY; COMPARATIVE STUDY; DISEASE CONTROL; EPIDEMIOLOGY; IMMUNITY; IMMUNIZATION; PREGNANCY; QUESTIONNAIRE SURVEY; RUBELLA; SERUM; TESTING METHOD; VACCINATION;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE CONTROL; DISEASE PREDISPOSITION; FEMALE; HEALTH PROGRAM; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; RUBELLA; SEROEPIDEMIOLOGY; SEROLOGY; VACCINATION; WORLD HEALTH ORGANIZATION;

AUSTRALASIA; AUSTRALIA; EURASIA; EUROPE;

RUBELLA;

EID: 38949148975     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.07.042010     Document Type: Article

References (32)

1. Plotkin SA, Reef S. Rubella vaccine. In: Vaccines. 4th ed. Plotkin SA, Orenstein WA eds. London: WB Saunders Co.; 2004. pp. 707-743.
2. Dudgeon JA. Selective immunisation: protection of the individual. Rev Infect Dis 1985;7:S185-90.
3. Plotkin SA. Rubella eradication. Vaccine 2001;19:3311-9. doi:10.1016/S0264-410X(01)00073-1
4. Spika JS, Wassilak S, Pebody R, Lipskaya G, Deshevoi S, Guris D, et al. Measles and rubella in the World Health Organization European region: diversity creates challenges. J Infect Dis 2003;187:S191-7. doi:10.1086/368336
5. Anderson RM, May RM. Vaccination against rubella and measles: quantitative investigations of different policies. J Hyg (Lond) 1983;90:259-325.
6. Panagiotopoulos T, Antoniadou I, Valassi-Adam E. Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review. BMJ 1999;319:1462-7.
7. Henquell C, Bournazeau JA, Vanlieferinghen P, Grangeot-Keros L, Chambon M, Lebel A, et al. [The re-emergence in 1997 of rubella infections during pregnancy. 11 cases in Clermont-Ferrand]. Presse Med 1999;28:777-80.
8. Strategic Plan for measles and congenital rubella infection in the European region of WHO. Copenhagen: WHO Regional Office for Europe; 2003.
9. Ukkonen P. Rubella immunity and morbidity: impact of different vaccination programs in Finland 1979-1992. Scand J Infect Dis 1996;28:31-5.
10. Eliminating measles and rubella and preventing congenital rubella infection. WHO European Region strategic plan 2005-2010. Copenhagen: WHO Regional Office for Europe; 2005.
11. Spika JS, Hanon FX, Wassilak S, Pebody R, Emiroglu N. Preventing congenital rubella infection in the European Region of WHO: 2010 target. Euro Surveill 2004;9:4-5.
12. Galazaka A. Rubella in Europe. Epidemiol Infect 1991;107:43-54.
13. Osborne K, Weinberg J, Miller E. The European Sero-Epidemiology Network (ESEN). Euro Surveill 1997;2:29-31.
14. Andrews N, Pebody RG, Berbers G, Blondeau C, Crovari P, Davidkin I, et al. The European Sero-Epidemiology Network: standardizing the enzyme immunoassay results for measles, mumps and rubella. Epidemiol Infect 2000;125:127-41. doi:10.1017/S0950268899004173
15. Pebody RG, Edmunds WJ, Conyn-van Spaendonck M, Olin P, Berbers G, Ribeiere I, et al. The seroepidemiology of rubella in western Europe. Epidemiol Infect 2000;125:347-57. doi:10.1017/S0950268899004574
16. Nardone A, Miller E. Serological surveillance of rubella in Europe: European Sero-Epidemiology Network (ESEN2). Euro Surveill 2004;9:5-7.
17. Tischer A, Andrews N, Kafatos G, Nardone A, Berbers G, Davidkin I et al. Standardisation of measles, mumps and rubella assays to enable comparisons of seroprevalence data across 21 European countries and Australia. Epidemiol Infect Mar 30:1-11 [epub ahead of print].
18. Kafatos G, Andrews N, Nardone A. Model selection methodology for inter-laboratory standardisation of antibody titres. Vaccine 2005;23:5022-7. doi:10.1016/j.vaccine.2005.05.030
19. Skendzel LP. Rubella immunity. Defining the level of protective antibody. Am J Clin Pathol 1996;106:170-4.
20. Mossong J, Putz L, Schneider F. Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study. Epidemiol Infect 2004;132:11-8. doi:10.1017/S0950268803001584
21. Vlaams infectieziektenbulletin 57/2006/3. Available from: www.wvc.vlaanderen.be
22. Edmunds WJ, van de Heijden OG, Eerola M, Gay NJ. Modelling rubella in Europe. Epidemiol Infect 2000;125:617-34. doi:10.1017/S0950268800004660
23. Edmunds WJ, Gay NJ, Kretzschmar M, Pebody RG, Wachmann H. European Sero-epidemiology Network. The pre-vaccination epidemiology of measles, mumps and rubella in Europe: implications for modelling studies. Epidemiol Infect 2000;125:635-50. doi:10.1017/S0950268800004672
24. Rafila A, Marin M, Pistol A, Nicolaiciuc D, Lupulescu E, Uzicanin A, et al. A large rubella outbreak, Romania - 2003. Euro Surveill 2004;9:7-8.
25. van der Veen Y, Hahne S, Ruijs H, van Binnendijk R, Timen A, van Loon AM et al. Rubella outbreak in an unvaccinated religious community in the Netherlands leads to cases of congenital rubella syndrome. Euro Surveill 2005 10:E051124.3.
26. Andrews N, Tischer A, Siedler A, Pebody RG, Barbara C, Cotter S, et al. Towards measles elimination: measles susceptibility in seventeen European countries and Australia. Bull World Health Organ [In press].
27. Davidkin I, Peltola H, Leinikki P, Valle M. Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland. Vaccine 2000;18:3106-12. doi:10.1016/S0264-410X(00) 00139-0
28. Vyse AJ, Gay NJ, Hesketh LM, Pebody R, Morgan-Capner P, Miller E. Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century. Epidemiol Infect 2006;134:1303-12. doi:10.1017/S0950268806006340
29. Pebody RG, Gay NJ, Hesketh LM, Vyse A, Morgan-Capner P, Brown DW, et al. Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance. Vaccine 2002;20:1134-40. doi:10.1016/S0264-410X(01)00435-2
30. Castillo-Solorzano C, Carrasco P, Tambini G, Reef S, Brana M, de Quadros CA. New horizons in the control of rubella and prevention of congenital rubella syndrome in the Americas. J Infect Dis 2003;187:S146-52. doi:10.1086/368034
31. Cohen D, Muhsen KH, Aboudy Y, Harari H, Mendelson E, Green MS. Use of rubella seroepidemiological data for assessment of previous vaccination policy and for decision making in response to epidemics in Israel. Vaccine 2006;24:5604-8. doi:10.1016/j.vaccine.2006.04.024
32. Kelly H, Worth L, Karapanagiotidis T, Riddell M. Interruption of rubella virus transmission in Australia may require vaccination of adult males: evidence from a Victorian sero-survey. Commun Dis Intell 2004;28:69-73.